5000272025-10-012025-12-315000272025-12-315000272025-04-012025-12-315000272025-10-012025-12-31in-capmkt:OtherExpenses1Member5000272025-10-012025-12-31in-capmkt:OtherExpenses2Member5000272025-04-012025-12-31in-capmkt:OtherExpenses1Member5000272025-04-012025-12-31in-capmkt:OtherExpenses2Member5000272025-10-012025-12-31in-capmkt:ReportableSegments1Member5000272025-10-012025-12-31in-capmkt:ReportableSegments2Member5000272025-10-012025-12-31in-capmkt:ReportableSegments3Member5000272025-04-012025-12-31in-capmkt:ReportableSegments1Member5000272025-04-012025-12-31in-capmkt:ReportableSegments2Member5000272025-04-012025-12-31in-capmkt:ReportableSegments3Member5000272025-10-012025-12-31in-capmkt:ReportableSegments1Member5000272025-10-012025-12-31in-capmkt:ReportableSegments2Member5000272025-10-012025-12-31in-capmkt:ReportableSegments3Member5000272025-04-012025-12-31in-capmkt:ReportableSegments1Member5000272025-04-012025-12-31in-capmkt:ReportableSegments2Member5000272025-04-012025-12-31in-capmkt:ReportableSegments3Member5000272025-10-012025-12-31in-capmkt:ReportableSegments1Member5000272025-12-31in-capmkt:ReportableSegments1Member5000272025-10-012025-12-31in-capmkt:ReportableSegments2Member5000272025-12-31in-capmkt:ReportableSegments2Member5000272025-10-012025-12-31in-capmkt:ReportableSegments3Member5000272025-12-31in-capmkt:ReportableSegments3Member5000272025-10-012025-12-31in-capmkt:ReportableSegments1Member5000272025-12-31in-capmkt:ReportableSegments1Member5000272025-10-012025-12-31in-capmkt:ReportableSegments2Member5000272025-12-31in-capmkt:ReportableSegments2Member5000272025-10-012025-12-31in-capmkt:ReportableSegments3Member5000272025-12-31in-capmkt:ReportableSegments3Member5000272025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15000272025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25000272025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15000272025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25000272025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15000272025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss25000272025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15000272025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss25000272025-10-012025-12-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares500027ATULNOTLISTEDINE100A01010ATUL LIMITEDMain BoardEquity2025-04-012026-03-312026-01-232025-12-26INRCroresQuarterlyThird quarterMulti segment2026-01-2310:00:002026-01-2314:10:00Declaration of unmodified opinion2025-10-012025-12-31UnauditedConsolidated157362000003859000001612210000074415000002871000005337000001667300000370000007980000003336000000141006000002021500000020215000003835000001590000039940000001622100000000133000001635400000-1604000001475000000160740000028000000-16040000002944000001054.654.60054.654.6These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. <BR> These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on January 22, 2026 and approved by the Board of Directors in its meeting held on January 23, 2026. The Statutory Auditors have carried out a limited review of the consolidated unaudited financial results for the quarter nine months ended on December 31, 2025. Their limited review report does not have any modification.The Company has reported segment information as per the Ind AS 108, 'Operating Segments', as below: <BR> <BR> Name of segment Main product groups <BR> Life Science Chemicals Active pharmaceutical ingredients and its intermediates, crop protection chemicals <BR> Performance and Other Chemicals Adhesion promoters, bulk chemicals, epoxy resins and hardeners, intermediates, textile dyes <BR> Others Agribiotech, food products, services and others <BR> The Government of India has consolidated 29 existing labour legislations into a unified framework comprising four labour codes (the new labour codes) on November 21, 2025. Accordingly, the Group has assessed the impact of these changes and, based on certain estimates and an actuarial valuation, has made an incremental provision2025-04-012025-12-31UnauditedConsolidated4603470000011333000004716800000023638600000709600000-21640000040787000001313000002428400000103237000004109390000060741000000607410000012625000007270000013352000000473890000000043800000478270000069210000054748000004677500000105200000692100000029440000010158.87158.8700158.87158.87Power, fuel and water1486500000Other Expenses1849500000Power, fuel and water4785600000Other Expenses5538100000Life Science Chemicals4543300000Performance and Other Chemicals11553900000Ohters186500000Life Science Chemicals13435000000Performance and Other Chemicals33674300000Ohters613000000162837000004772230000054750000016876000001573620000046034700000Life Science Chemicals1046600000Performance and Other Chemicals878900000Ohters30900000Life Science Chemicals2740000000Performance and Other Chemicals2917300000Ohters1058000001956400000576310000037000000131300000-115400000-44230000020348000006074100000Life Science Chemicals13181400000Performance and Other Chemicals37546300000Ohters2454000000531817000002292270000076104400000Life Science Chemicals2821100000Performance and Other Chemicals8356600000Ohters23700000011414700000333410000014748800000These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. <BR> These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on January 22, 2026 and approved by the Board of Directors in its meeting held on January 23, 2026. The Statutory Auditors have carried out a limited review of the consolidated unaudited financial results for the quarter nine months ended on December 31, 2025. Their limited review report does not have any modification.The Company has reported segment information as per the Ind AS 108, 'Operating Segments', as below: <BR> <BR> Name of segment Main product groups <BR> Life Science Chemicals Active pharmaceutical ingredients and its intermediates, crop protection chemicals <BR> Performance and Other Chemicals Adhesion promoters, bulk chemicals, epoxy resins and hardeners, intermediates, textile dyes <BR> Others Agribiotech, food products, services and others <BR> The Government of India has consolidated 29 existing labour legislations into a unified framework comprising four labour codes (the new labour codes) on November 21, 2025. Accordingly, the Group has assessed the impact of these changes and, based on certain estimates and an actuarial valuation, has made an incremental provisionFair value of equity instruments through other comprehensive income-244100000Remeasurement gain/ (loss) on defined benefit plans16900000-227200000Fair value of equity instruments through other comprehensive income614000000Remeasurement gain/ (loss) on defined benefit plans23500000637500000-30600000100300000Effective portion of gain/ (loss) on cash flow hedges1900000Exchange differences on transiation of foreign operations3600000037900000Effective portion of gain/ (loss) on cash flow hedges0Exchange differences on transiation of foreign operations16460000016460000017000009700000-160400000692100000UnauditedtrueDeloitte Haskins and Sells LLPtrue2027-07-31